🗣️ Workshop title: Navigating the EU Regulatory Maze to Conduct International Medical Research Developing AI
📍 Location: Maison de la Poste
🕒 Date & time: Friday, 22 May | 14:15–15:30 CET
🌍 Conference: CPDP 2026 – Computers, Privacy and Data Protection

The session will explore the regulatory and data protection challenges surrounding international AI-driven medical research across Europe.

➡️ More information here:
https://lnkd.in/d2FCHYMA

➡️ Check video on Linkedin

The post Workshop at Computers, Privacy and Data Protection Conference (CPDP) appeared first on I³LUNG.

The #I3LUNG partners are involved in these sessions:

➡️ Bias at the source: understanging and mitigating data imbalances in NSCLC and immunotherapy (Vanja Mišković)
➡️ AI-driven pathology in clinical practice: head and neck and other cancrs example use case (Alexander Pearson)
➡️ LLMs for target and drug discovery: a personalized therapy for every single patient (Matteo Sacco)
➡️ Transforming oncology patient journey with agentic AI (Francesco Trovò)

Of course Arsela Prelaj as co-president of the conference.
And Helena Linardou and Alessandra Pedrocchi as part of the scientific committee.

Find the program and more information here: https://lnkd.in/dReRmhz4

The post ESAC: First Annual Meeting (AI for oncology) appeared first on I³LUNG.

As cancer care shifts toward biomarker-driven, AI-supported treatment decisions, many existing NSCLC models still overlook diagnostic performance and misclassification, despite their critical impact on patient outcomes.

Based on a review of 237 published models, this work calls for a shift toward modelling treatment strategies, linking decision rules, treatment assignment, and patient pathways over time.

It also highlights the role of open-source platforms in improving transparency, validation, and collaboration in increasingly complex decision-making.

🔗 https://lnkd.in/dqUjSp7Z

#HealthEconomics #EuropeanFundedProject

The post 2026 Swedish Health Economics Conference (SHEA) appeared first on I³LUNG.

An achievement that recognizes the transformative potential (and initial successes) of #AI for cancer care and research!

What a meaningful milestone that inspires us to continue pushing innovation forward for patients, researchers, and the future of oncology and AI. 🤖💙

#GoTeamI3LUNG

The post We gained the first prize in the “Innovators Category” appeared first on I³LUNG.

🧠 Session: AI-based procedures to augment clinical trials
🕥 Time: 10:15 – 11:45

The session will feature leading experts in the field, including Dr. Arsela Prelaj (Milan, Italy), who will open the session with her lecture:
🎙️ 10:15 – 10:30 | AI for genomic precision medicine in clinical trials

Chaired by:
👩‍⚕️ Mihaela Aldea (Villejuif, France)
👨‍⚕️ Jakob Nikolas Kather (Dresden, Germany)

The post How is artificial intelligence reshaping the landscape of oncology clinical trials? appeared first on I³LUNG.

📍: Hanover Auditorium – Hall 7.2c
🕐: 14:00 – 15:30

We’re ready for another excellent congress ahead! 🫁🇪🇺

The post Kicking-off #ESMO25 at the International Congress Center MESSE in Berlin, Germany. appeared first on I³LUNG.

Artificial intelligence is revolutionizing how we design and conduct clinical trials in oncology. On November 6th, leading experts will gather in Rome for “AI in Clinical Trials”, organized by ESAC – European Interdisciplinary Society of AI for Cancer Research, to explore innovative trial designs, trustworthy AI implementation, and real-world data applications.

You can follow the event in person or online.

🔗 To register, click here

The post AI in Clinical Trials appeared first on I³LUNG.

The World Conference on Lung Cancer (WCLC), organized by the IASLC, brought together passionate minds and lung cancer experts from around the world, and I3LUNG was right there in the mix. Here’s how we made our mark with five bold moves during the congress. 

1. We kicked things off with bold conversations at the IST Innovation Forum on September 6

On day 1 of the Congress, MEDSIR from work package 1 and 10, hosted a side event that got people talking. One of the topics during IST Innovation Forum was how AI can boost innovation in investigator-sponsored trials. Our own Dr. Arsela Prelaj led a thought-provoking session on how data and algorithms are reshaping clinical trials from the inside out. 

2. We listened to coughs: yes, coughs, to detect cancer. Poster P1.04.51, on September 7 at 10:30 AM

On Sunday morning, Arsela presented our research on multimodal cough analysis as a pre-screening tool for NSCLC. The idea? Using AI to catch subtle audio and signal patterns in patients’ coughs to detect lung cancer earlier and less invasively. It sparked curiosity. Some attendees stayed and asked questions, intrigued by how something as ordinary as a cough could play a role in early detection. 

3. PD-L1 predictions from H&E whole-slides images. Poster P2.06.65, September 8 at 10:30 AM

 Vanja Stojanovic, from POLIMI partner, presented our ensemble AI model capable of predicting PD-L1 expression from standard H&E whole-slide images. Translation: fewer extra tests, faster insights, and a new way to support clinical decisions using data we already have. 

A great way to start a conversation on how far pathology can go when teamed up with tech. Watch video here.

4. Oral sessions are always a highlight at #WCLC2025! 

This oral on “A Multimodal AI-Based Clinical Decision Support System for Predicting Immunotherapy Efficacy in Metastatic NSCLC” marks an important milestone for our project, and we are grateful to all the colleagues and collaborators whose dedication makes every study, every paper, and every presentation possible.

5. We hit the plenary stage and talked big data, big impact. PL04.03, September 9 at 8:30 AM

 Yes, the plenary. On Tuesday morning, bright and early, Dr. Arsela Prelaj took the spotlight for “Data-Driven Oncology: How Big Data and AI Can Transform Lung Cancer.” 

For 15 minutes, the room was fully tuned in. She painted a clear picture of how multimodal data (spanning clinical records, scans, pathology, and genomics) can help us move from “one-size-fits-all” to personalized, precise, and smarter treatment decisions.  

From poster sessions to plenary talks, from after-hours brainstorms to spontaneous reunions with colleagues across Europe and beyond, WCLC 2025 had it all. The I3LUNG team was once again energized and inspired to keep pushing the boundaries of lung cancer care. 

See you next year, #WCLC26! 

The post Another successful World Conference on Lung Cancer (WCLC) for I3LUNG appeared first on I³LUNG.

Being part of such a prestigious session highlights the growing importance of data and AI in the future of lung cancer care, and it was a great opportunity to showcase I3LUNG’s commitment to innovation in thoracic oncology.

👏 Congratulations, Arsela, for this important contribution to the scientific community!

The post Arsela Prelaj represents I3LUNG at the WCLC 2025 Scientific Plenary appeared first on I³LUNG.

This oral marks an important milestone for our project, and we are grateful to all the colleagues and collaborators whose dedication makes every study, every paper, and every presentation possible.

Great job, Arsela Prelaj and all the team involved.

The post 🚨 Oral sessions are always a highlight at #WCLC2025! appeared first on I³LUNG.